Cost containment by peer prior authorization program for second line treatment in patients with retinal disease

BACKGROUND: High and increasing drug prices have prompted the establishment of a broad range of cost-containment treatment policies in health systems globally. In 2012, the supplemental insurance program of a large Israeli health maintenance organization (Clalit Health Services) introduced a prior a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenblatt, Amir, Hekselman, Igal, Rosenblatt, Irit, Hekselman, Idan, Gaton, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Integrative Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830824/
https://www.ncbi.nlm.nih.gov/pubmed/33494826
http://dx.doi.org/10.1186/s13584-021-00437-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830824/
https://www.ncbi.nlm.nih.gov/pubmed/33494826
http://dx.doi.org/10.1186/s13584-021-00437-1

Ejemplares similares